← Leaderboards
Jane Hill
Dartmouth College
$1,565,877
Attributed
$2,617,407
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $514.3K · FY2016–22$1M$750K$500K$250K$0
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$2,617,407 · 3
By mechanism
R01$1,654,316 · 1
R56$514,347 · 1
R21$448,744 · 1
Top collaborators
- Jerry A Nick4 shared
- Lennart Karl Alf Lundblad2 shared
Most similar at Dartmouth College
Same institution · by research overlap
- Jennifer Melinda Bomberger$8,401,829
- George A. O'Toole$25,085,923
- Bruce A. Stanton$36,066,326
- Nancy Asmussen Speck$24,014,699
- Zhigang Li$4,408,676
Others in their field
Top investigators on “Sputum”
- David Alland · Rutgers Biomedical And Health Sciences$42,990,070
- Prescott G Woodruff · University Of California San Francisco$40,032,105
- Steven A Belinsky · Lovelace Biomedical &Environmental Res$32,518,261
- John V Fahy · University Of California San Francisco$26,958,071
- William N Rom · New York University School Of Medicine$20,092,475
- Richard C Boucher · University Of North Carolina Chapel Hill$16,676,955
Research focus
SputumDiagnosisInfectionPathogenCo-InfectionMonitorSamplingChildhoodAdultDetectionAntibiotic ResistanceRespiratoryResponseEvaluationBaseMolecularLung DiseasesEarly DiagnosisCystic FibrosisCystic Fibrosis PatientsDecontaminationClinical Trials DesignCross-Sectional StudiesData Analyses
Grant awards (7)
Prospective Longitudinal Assessment of Culture-Independent Molecular Airway Markers of Nontuberculous Mycobacteria$410,000
R01 · FY2022 · HL
Prospective Longitudinal Assessment of Culture-Independent Molecular Airway Markers of Nontuberculous Mycobacteria$410,000
R01 · FY2021 · HL
Prospective Longitudinal Assessment of Culture-Independent Molecular Airway Markers of Nontuberculous Mycobacteria$410,000
R01 · FY2020 · HL
Prospective Longitudinal Assessment of Culture-Independent Molecular Airway Markers of Nontuberculous Mycobacteria$424,316
R01 · FY2019 · HL
Improving outcomes in CF patients: Toward rapid detection of P. aeruginosa$514,347
R56 · FY2018 · HL · contact PI
Toward Rapid, Non-Invasive, Highly Sensitive, Multiplex Detection of Respiratory Pathogens$196,372
R21 · FY2017 · AI · contact PI
Toward Rapid, Non-Invasive, Highly Sensitive, Multiplex Detection of Respiratory Pathogens$252,372
R21 · FY2016 · AI · contact PI